Patent · US Active

Gene correction of SCID-related genes in hematopoietic stem and progenitor cells

US9616090B2 · kind B2 · utility

42Cited by

55References

19Claims

0Family size

Assignee

Sangamo Biosciences, Inc. · US

Inventors

Anthony J. Conway · Chatfield, US
Gregory J. Cost · Berkeley, US
Michael C. Holmes · Richmond, US
Fyodor Urnov · Richmond, US

Key dates

Filing date	Jul 30, 2015
Grant date	Apr 11, 2017
Priority date	—
Expiry date	Jul 30, 2035

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61K2035/124
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The present disclosure is in the field of genome engineering, particularly targeted integration of a functional SCID-related genes (e.g., IL2RG, RAG1 and/or RAG2 gene) into the genome of a cell for provision of proteins lacking or deficient in SCID.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.